|
|
||||||||
1 Department of Pharmacology and Toxicology and 2 Vascular Biology Center, Medical College of Georgia, Augusta, Georgia 30912; and 3 Department of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, North Carolina 27157
| |
ABSTRACT |
|---|
|
|
|---|
Insulin resistance (IR) syndrome is associated with impaired vascular relaxation; however, the underlying pathophysiology is unknown. Potassium channel activation causes vascular smooth muscle hyperpolarization and relaxation. The present study determined whether a reduction in large conductance calcium- and voltage-activated potassium (BKCa) channel activity contributes to impaired vascular relaxation in IR rats. BKCa channels were characterized in mesenteric microvessels from IR and control rats. Macroscopic current density was reduced in myocytes from IR animals compared with controls. In addition, inhibition of BKCa channels with tetraethylammonium (1 mM) or iberiotoxin (100 nM) was greater in myocytes from control (70%) compared with IR animals (~20%). Furthermore, activation of BKCa channels with NS-1619 was three times more effective at increasing outward current in cells from control versus IR animals. Single channel and Western blot analysis of BKCa channels revealed similar conductance, amplitude, voltage sensitivity, Ca2+ sensitivity, and expression density between the two groups. These data provide the first direct evidence that microvascular potassium currents are reduced in IR and suggest a molecular mechanism that could account for impaired vascular relaxation in IR.
potassium channels; BKCa channel
| |
INTRODUCTION |
|---|
|
|
|---|
INSULIN RESISTANCE (IR), with its associated hyperinsulinemia, is a common metabolic disorder in the adult population of prosperous societies (32) and has traditionally been defined as impairment in the signaling pathway linking insulin to its metabolic effects. A serious complication of IR is increased cardiovascular morbidity and mortality (12), with a higher incidence of both hypertension (21) and atherosclerosis (12). Moreover, IR is also associated with characteristic features that are themselves cardiovascular risk factors, including dyslipidemia characterized by low high-density lipoproteins, elevated triglycerides, and high low-density lipoproteins (11, 14, 27). Athough IR is a widely accepted risk factor for the development of hypertension and ischemic heart disease, the exact mechanism by which IR promotes vascular disease/dysfunction remains largely unknown. Several mechanisms have been proposed during the last decade to account for this impaired vascular function. For example, increased catecholamine outflow from the sympathoadrenal system is associated with hyperinsulinemia, whereas sympathectomy prevents high-fructose diet-induced hyperinsulinemia and hypertension (42). On the other hand, plasma norepinephrine levels were not altered in a group of hyperinsulinemic patients (28), and another study (41) demonstrated that heightened sympathetic activity did not contribute to IR-related hypertension.
There is substantial evidence suggesting that altered vascular reactivity in IR may be attributed to impaired endothelium-dependent vasodilation. Patients with IR exhibit depressed endothelium-mediated relaxation to increasing doses of methacholine (1, 40). Similar results were observed in patients with non-insulin-dependent diabetes (44) and microvascular angina (35), which are commonly associated with the IR syndrome (25). Moreover, animal studies have demonstrated impaired endothelium-dependent relaxation responses in both macro- and microvessels from the fructose-fed rat model of IR. Specifically, we (17) demonstrated that impaired relaxation to acetylcholine in small mesenteric arteries from IR rats develops before the onset of hypertension. Furthermore, it has been suggested that this impaired relaxation response might be attributed to reduced potassium conductance through calcium-activated potassium channels in microvascular smooth muscle; however, potential effects of IR on potassium channels in vascular myocytes are unknown. The objective of the present study was to directly examine alterations in the activity of the large conductance calcium- and voltage-activated potassium (BKCa) channel in vascular myocytes from IR animals. We examined the effects of IR on both the expression of this channel and its activity at both the macroscopic (whole cell) and microscopic (single channel) level. Our findings indicate that IR depresses the activity of BKCa channels in vascular myocytes from resistance arteries, which could impair vascular relaxation. This defect may contribute to the hypertension so often associated with the IR syndrome.
| |
METHODS |
|---|
|
|
|---|
Animals. Male Sprague-Dawley rats were obtained at 6 wk of age and randomized into one of two groups: IR or control animals. The IR group was fed a fructose-rich diet (containing 66% fructose, 22% casein, and 12% lard plus essential vitamins and minerals, Teklad Labs; Madison, WI), and control animals received standard rat chow. We (17) previously demonstrated that fructose-fed rats develop IR within 7 days, endothelial dysfunction within 14 days, and borderline hypertension within 20-28 days of diet therapy. Each group of animals was continued on their respective diets for a period of 4 wk. Glucose clamp experiments and glucose tolerance tests have been performed, establishing that this model does develop IR at the level of the skeletal muscle (4, 15). This was shown to correlate with fasting hyperinsulinemia in this model. In the present experiments, fasting hyperinsulinemia was used as a marker for the development of IR.
Measurement of blood pressure. One day before diet treatment was ended, rats were sedated with pentobarbital sodium (30 mg/kg ip) and ketamine (1 mg/kg ip). With use of an aseptic technique, an arterial cannula [polyethylene (PE)-10 tubing coupled to PE-50 tubing] was placed into the femoral artery for measurement of arterial pressure. The external portion of the cannula (PE-50) was tunneled under the skin, sutured between the scapula, and filled with heparinized saline solution. Animals were allowed to recover from this procedure for 24 h. During the first 18 h of the recovery period, all animals had free access to food and water. This period was followed by a 6-h fast. After the recovery period, the arterial cannula was aligned to a fluid-filled transducer (CPXL-23, Statham; Costa Mesa, CA), and the signal was conditioned, amplified, and digitized for measurement of conscious, unrestrained blood pressure. Animals were allowed to acclimatize to their new environment for 30 min before blood pressure was recorded. All data were fed on-line to an IBM personal computer and an analog-to-digital converter. Acquisitions of blood pressure were taken every 20 s for a period of 30 min. Software (DataQ, Windaq) stored the blood pressure for each experiment. These data were averaged for each animal to determine the mean resting blood pressure.
Biochemical measurements. After blood pressure measurements, rats (after a 6-h fasting period) were anticoagulated (500 units ip heparin) and anesthetized (50 mg/kg ip pentobarbital sodium). A midline incision was made, and the abdominal and chest cavities were opened. A 1-ml blood sample was drawn from the left ventricle for evaluation of fasting serum insulin and glucose concentrations. Plasma insulin was assayed by using a dextran-coated charcoal immunoassay (13). Glucose concentrations were measured using a Glucose Trinder kit (Sigma; St. Louis, MO).
Isolation of single mesenteric smooth muscle cells. Myocytes were isolated daily from third- or fourth-order mesenteric small arteries by a modification of a previously described procedure (7). Briefly, the endothelium was removed, and the adventitia of microvessels were dissected away under a microscope. The remaining smooth muscle-rich media layer was digested in an enzyme solution consisting of 6 mg papain, 4 mM dithiothreitol, 2 mg collagenase, and 0.02% bovine serum albumin. After 30 min of gentle shaking, muscle strips were lightly triturated, and the enzyme solution was diluted by the adding excess enzyme-free solution. The solution was then removed and centrifuged at 500 rpm for 12 min. The pellet was resuspended in fresh medium containing (in mM) 110 NaCl, 5 KCl, 2 CaCl2, 2 MgCl2, 10 HEPES, 10 NaHCO3, 0.5 KH2PO4, 10 glucose, 0.49 EDTA, and 10 taurine. For patch-clamp experiments, several drops of cell suspension were placed in a microscope chamber containing the appropriate recording solution.
Ion channel recording. Whole cell currents were measured from metabolically intact cells using the amphotericin perforated patch technique (7). In contrast to standard whole cell techniques, perforated patch recordings provide current measurements with only minimal decay of the current or loss of soluble cytoplasmic components due to cellular dialysis. Furthermore, endogenous calcium-buffering systems are not inactivated by dialyzing the cell with calcium chelators, as are required during whole cell recordings. The identification and characterization of single ion channels were also assessed.
Perforated patch experiments.
Cells were placed in a recording solution (22-25°C) of the
following composition (in mM): 140 NaCl, 5 KCl, 1 CaCl2, 2 MgCl2, 20 HEPES, and 20 glucose (pH 7.4). Patch pipettes
were fabricated from Corning 7052 glass (Garner Glass) using a P-87
Flaming-Brown pipette programmable puller. Pipettes with a resistance
of 3 M
or less were used to record ion channel activity. To measure
whole cell potassium currents, the tips of patch pipettes were filled with a solution containing (in mM) 90 KCH3SO3,
40 KCl, 5 MgCl2, and 20 HEPES to approximate normal
cellular [K+] and [Cl
] (pH. 7.2 with
KOH). The remainder of the pipette was back filled with a similar
solution to which 200 mg/ml amphotericin B (diluted with dimethyl
sulfoxide) was added. Leak-subtracted currents were recorded with an
Axopatch 200-B amplifier (Axon Instruments) and analyzed with pCLAMP
7.0 software. All drugs were diluted into fresh bath solution and
perfused into the 0.5-ml recording chamber.
Single channel recordings.
Single potassium channels were measured in cell-attached patches by
filling the patch pipettes (2-5 M
) with the standard bath
solution and making a gigaohm seal on an intact cell. The solution in
the recording chamber contained (in mM) 140 KCl, 10 MgCl2,
0.1 CaCl2, 10 HEPES, and 30 glucose (pH 7.4). This
manipulation allows precise regulation of the patch membrane voltage by
the patch-clamp amplifier and yields more accurate current
measurements. In experiments measuring potassium channel activity in
cell-free inside-out patches, the solution facing the cytoplasmic
surface of the membrane had the following composition (in mM): 115 KCH3SO3, 26 KCl, 2 MgCl2, 1 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid, 0.47 CaCl2 (pCa 7), 5.0 Mg-ATP, 0.1 GTP, and 20 HEPES
(pH 7.2). The solution facing the external surface was the standard recording solution described above. Currents were filtered at 2 kHz,
digitized at 10 kHz, and analyzed as described above. Channel activity
was quantified by calculating the single channel open probability
(NPo) as described previously (43).
Expression of BKCa channels by immunoblotting.
Small mesenteric arteries (similar size to those used in ion channel
recordings) were manually dissected and placed in ice-cold homogenization buffer containing protease inhibitors and (in mM) 50 Tris · HCl (pH 7.7), 0.1 EDTA, 1 EGTA, 250 sucrose, 0.1%
2-mercaptoethanol, 10% glycerol, 1 phenylmethylsulfonyl fluoride, 1 pepstatin A, 2 leupeptin, and 0.1% aprotein. The vessels were
homogenized with a glass/glass homogenizer, and the homogenate was
centrifuged at 1,000 g for 10 min, followed by a second
centrifugation at 14,000 g for 15 min at 4°C. The
supernatant was used for Western blot analysis as described in detail
(24). A site-specific antibody directed against amino
acids 913-926 of the S9/S10 linker of the
-subunit of the
BKCa channel, used previously in rat mesenteric and other
vessels, was used (22). The bound antibody was detected by
enhanced chemiluminescence (Amersham), and the densities of the
immunoreactive bands associated with anti-
913-926
were normalized to the
-actin density in each lane
(22).
Chemicals. All chemicals used in this study were obtained from Sigma.
Statistics. Means and SE were calculated for systolic blood pressure, weight, serum insulin levels, and serum glucose levels for each group. Statistical differences between the control group and the group that received the fructose-rich diet were calculated for each of the above parameters using a one-way ANOVA for multiple comparisons. All data are reported as means ± SE. The criteria for significance were P < 0.05. Mean values were based on the number of animals used in each experimental group (n).
| |
RESULTS |
|---|
|
|
|---|
Animal weight, mean arterial pressure, fasting plasma insulin
levels, and fasting glucose levels are provided in Table
1. There was no difference in mean
fasting plasma glucose levels between the control and IR groups, which
is consistent with our previous data (18) demonstrating
that these animals were not yet diabetic at the time of experiments (28 days of fructose-fed diet). However, mean fasting plasma insulin levels
and mean arterial pressure were elevated significantly in IR animals
compared with controls. These findings are consistent with other
investigations indicating that after 28 days of fructose-fed diet the
animals exhibit characteristics of hyperinsulinemia and hypertension
(17).
|
Ion channel activity.
We (18) suggested previously that impaired relaxation of
arteries from IR animals might be attributed to dysfunction of BKCa channels. In vascular smooth muscle cells (VSMC), the
macroscopic outward current is conducted primarily by K+
efflux through BKCa channels. Therefore, we examined whole
cell steady-state outward K+ currents in single myocytes
isolated from IR and control animals. These experiments were performed
in metabolically intact muscle cells (perforated patch technique) from
mesenteric microvessels. Macroscopic K+ currents were
generated by incremental 10-mV depolarizing steps (from
50 to +50
mV), and the family of outward currents is illustrated in Fig.
1, A and B.
Currents were significantly lower in myocytes from IR animals compared
with controls. Currents activated slowly and did not inactivate in
either group of myocytes during the 200-ms depolarization. This kinetic
profile suggested activity of BKCa channels. The complete
current-voltage relationship of average K+ current
densities (in pA/pF) for cells from IR and control animals is provided
in Fig. 1C. The macroscopic outward current was decreased at
all positive voltages in myocytes from IR animals compared with
controls, with no shift in the threshold for activation. For example,
maximum current density at the peak of the curve (+50 mV) was 20% less
in mesenteric microvascular cells from IR animals than those from
controls [21 ± 1.5 (n = 4) vs. 26 ± 0.8 (n = 4) pA/pF, respectively]. Membrane capacitance, an
indicator of cell membrane area, was not significantly different
between control and IR animals, averaging 15.2 ± 1 and 14.1 ± 0.9 pF, respectively.
|
|
|
NS-1619 and K+ channel activity.
Superfusion of control cells with NS-1619 (10 µM), a selective
BKCa channel activator, markedly increased the macroscopic K+ current in myocytes from control rats by almost twofold
(from 370 to 640 pA; Fig. 4). Typical
current traces before and after NS-1619 in mesenteric microvascular
myocytes from control and IR animals are illustrated in Fig.
4A. The maximum NS-1619-stimulated current generated at +50
mV was 700 pA in control cells; however, the response of myocytes from
IR animals to the channel agonist was significantly blunted. On
average, NS-1619 increased outward current in myocytes from IR rats by
21 ± 5.4% (n = 4), whereas the increase observed
in controls was 63.7 ± 3.4% (n = 4). The complete current-voltage relationship for current density from control
and IR cells before and after NS-1619 is illustrated in Fig. 4,
C and D.
|
BKCa channel
-subunit expression.
The decreased macroscopic current observed in IR animals could result
from decreased channel expression; therefore, we examined the
expression of the
-subunit of the BKCa channel in
mesenteric smooth muscle membranes from control and IR animals.
Previous control studies (20, 24) have established the
specificity of the primary antibody anti-
913-926
for its recognition site on the
-subunit of the BKCa
channel. A typical immunoblot of
-subunit expression is illustrated
in Fig. 5. Lanes were loaded with either
control or IR membrane proteins and revealed no apparent difference in
the density of the 125-kDa immunoreactive band. Stripping and
rehybridization of the membranes with the monoclonal antibody for the
42-kDa protein
-actin revealed the same signal density for this
internal standard, demonstrating uniformity of lane loading. The
density signal of the
-actin internal standard was not different
between the control and IR preparations. The data average from
different Western blot experiments using membranes from different rats
indicated that the density of the 125-kDa immunoreactive band
(expressed as a percentage of the
-actin signal) was similar in
control and IR animals.
|
Single channel properties.
We next examined the possibility that altered single channel properties
contributed to the decrease in outward current in mesenteric
microvessels myocytes from IR animals. Unitary current amplitude was
plotted as a function of membrane potentials (
60 and +60 mV) in Fig.
6. The resulting microscopic
current-voltage relationship yielded a mean single channel slope
conductance of 142.6 ± 4 pS (n = 3 animals and 6 patches) and 134.3 ± 6 pS (n = 3 animals and 6 patches) for cells from control and IR animals, respectively, and these
values were similar to BKCa channel conductances reported
previously (10). The recordings of single channel currents obtained at various membrane potentials were similar for inside-out patches from control and IR rats (data not shown).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
IR syndrome is characterized by high risk for the development of non-insulin-dependent diabetes and accompanying vascular diseases including hypertension, atherosclerosis, and vasospastic angina (37). These vascular disorders have two common features: relative resistance to insulin-mediated glucose uptake (8) and vascular endothelial dysfunction (6, 44); however, our understanding of how hyperinsulinemia affects VSMC is far from complete. Although insulin has little effect on glucose uptake into vascular cells (14), it has a variety of other actions in VSMC. Insulin potentiates the effects of several growth factors, i.e., platelet-derived growth factor and mitogen-activated protein kinase, to promote vascular smooth muscle proliferation (2), production of extracellular matrix, and cell migration (14). Functionally, insulin has also been implicated as a vasoactive hormone. A recent report (8) suggests insulin mediates vasodilation via an endothelium-dependent mechanism. On the other hand, insulin can directly decrease intracellular Ca2+ levels in VSMC, causing relaxation and reduced reactivity to vasoconstrictors in the absence of endothelium (16). Potential mechanisms accounting for these vascular effects include stimulation of the Na+/H+ exchanger and Na+-K+-ATPase, leading to hyperpolarization of the cell membrane and consequent closure of voltage-gated Ca2+ channels (8). Thus, insulin may relax vascular smooth muscle via endothelium-dependent and -independent mechanisms, leading to an interesting conundrum observed in IR patients: Why does hypertension develop in the presence of excess vasodilator (i.e., insulin)?
The specific etiology of hypertension and atherosclerosis in the IR state has not been clearly defined. One possibility is that endothelial dysfunction occurs at a very early stage in the IR syndrome (26), and the loss of endothelial function promotes vasoconstriction and vascular smooth muscle growth (34, 39). Indeed, recent clinical and animal studies support this contention. IR patients exhibit impaired endothelium-mediated vasodilation (40), as do small mesenteric arteries from IR animals (18). Because endothelium-derived relaxing factors hyperpolarize VSMC by opening smooth muscle potassium channels (7, 29), it has been suggested that the impaired endothelium-dependent relaxation in IR might be related to abnormal potassium channel activity in VSMC (18); however, the potential effects of IR on potassium channel function are unknown. With the use of a multifaceted approach (i.e., patch clamp and Western blots), we now provide direct evidence that IR impairs BKCa channel function in VSMC from mesenteric microvessels.
It has become increasingly apparent that VSMC potassium channels are affected by a variety of pathological states that alter the integrity and/or excitability of vascular smooth muscle. Like many smooth muscle cells, myocytes from small mesenteric arteries exhibit substantial outward K+ currents (7), leading to membrane repolarization and relaxation by closing voltage-dependent Ca2+ channels. Although several distinct K+ channels are expressed in VSMC (5), the predominate type expressed in mesenteric artery smooth muscle is the BKCa channel (7, 10). These channels are identified by their selectivity and large single channel conductance as well as their sensitivity to membrane voltage and intracellular [Ca2+] (9). In the present study, the macroscopic outward K+ current density was significantly attenuated in mesenteric myocytes from IR animals compared with controls. More specifically, the TEA- or IbTX-sensitive component of the macroscopic K+ current was markedly less in myocytes from IR rats. These findings suggest that the contribution of BKCa channels to the outward current is significantly reduced in IR and probably accounts for the reduced current density observed in myocytes from IR animals. It is also possible that the reduction in outward current might reflect alteration of other potassium channels (e.g., ATP-sensitive K+ or voltage-dependent K+ channels); however, it is clear that BKCa channels predominate in mesenteric microvascular myocytes and that influence of these channels is suppressed in the IR state. Furthermore, the stimulatory effect of a BKCa channel activator, NS-1619, was substantially reduced in myocytes from IR animals. Thus the initial findings of the present study, i.e., that IR myocytes showed a diminished BKCa channel current, could clarify the cellular basis for impaired vasorelaxation and development of hypertension in the IR state. These findings are supported by previous studies (36) indicating changes in cardiac K+ currents in hyperinsulinemic conditions but contrast with those of Liu et al. (23) reporting increased potassium current in the aorta from aldosterone-salt hypertensive rats. This apparent discrepancy probably reflects differences in the macrovascular (aorta) vs. the microvascular preparations employed in the present study. Interestingly, insulin stimulates calcium-dependent outward K+ conductance of bovine retinal capillary pericytes (3); although these cells are not VSMC, they exhibit electrical properties similar to smooth muscle and are thought to be involved in regulation of the retinal microcirculation. Therefore, the BKCa channel appears to be an important molecular target of insulin action.
Further experiments were performed to explore the mechanism responsible
for the decrease in total membrane current density in mesenteric
myocytes from IR animals. Changes in macroscopic current reflect the
contribution of channel number or expression (N), unitary
current amplitude (i), and channel open state probability (Po). Thus N, i, and
Po are distinct parameters that could be altered
in the IR state to account for the decrease in macroscopic BKCa current density. With the use of a site-directed
antibody targeted against the S9/S10 linker of the BKCa
channel (20), we detected no difference in the density of
a 125-kDa immunoreactive band in membranes from IR animals compared
with controls. The 125-kDa band corresponds to the known molecular size
of the
-subunit of the BKCa channel (19).
These findings suggest that the decreased current density in myocytes
from IR animals is not related to altered expression of the
pore-forming subunit of the BKCa channel. An important
caveat, however, must be considered in interpreting these data from
Western blots. These experiments detect protein expression, and it is
difficult to account for potential effects of IR on posttranslational
modification or trafficking of BKCa channel proteins
between the cytoplasm and the plasma membrane. Therefore, while these
immunoblot studies certainly suggest no changes in overall
BKCa channel expression in IR animals, they cannot rule out
potential effects of IR that could render channel complexes
nonfunctional. In contrast, previous studies (24) have
reported that VSMCs from hypertensive animals (spontaneously hypertensive rats) exhibit a significant increase in the density of a
125-kDa immunoreactive band compared with normotensive animals. In IR animals, blood pressure does not increase until around 28 days
after induction of the IR state (17). Because we employed 28-day IR animals that were borderline hypertensive, we did not expect
to see a similar increase in expression. Therefore, the suppression of
BKCa current observed in myocytes from IR animals may be
related to altered channel function, and subsequent patch-clamp studies
were performed to address this possibility.
We did not observe a difference in single channel current amplitude in
VSMC cell patches from IR or control animals, nor was there a
difference in the calculated single-channel slope conductance (Fig. 5).
These findings strongly suggest that decreased current density observed
in myocytes from IR rats cannot be attributed to altered single channel
amplitude (i). The other factor that would decrease
macroscopic BKCa current is a lower
Po of the BKCa channel. In IR, the
-subunit may exhibit decreased gating sensitivity or defective
coupling to accessory subunits affecting voltage and/or calcium
sensitivity, thereby reducing current density independent of changes in
channel expression (24). For example, the
-subunit of
the BKCa channel affects the Ca2+ sensitivity
(33). Thus if the IR state altered the expression or
function of the
-subunit, this should manifest as altered sensitivity of channel Po to intracellular
[Ca2+]. These two main determinants of the
BKCa channel Po, i.e., the ability
to sense changes in transmembrane voltage and intracellular Ca2+, were examined in the single channel experiments.
These studies revealed a similar relationship between voltage and
single BKCa channel Po in myocytes
from IR or control animals. Furthermore, the sensitivity of channel
Po to intracellular [Ca2+] was
also similar. It has been suggested that the conductance and voltage
dependence of BKCa channels are determined by the NH2-terminal core, whereas Ca2+ sensitivity
appears to involve a region of several negatively charged residues at
the COOH-terminal core (20). Therefore, our results
suggest that the NH2- and COOH-terminal cores of the BKCa channel appear to be functionally intact in myocytes
from IR animals, further suggesting that IR probably does not produce significant alterations in the structure or coupling of the
BKCa channel protein complex.
However, one must be cautious in extrapolating the results from these experiments on excised patches to intact cells or tissue. In our inside-out patch experiments, the concentration of free "intracellular" Ca2+ is carefully regulated; however, in intact cells, the localization and amount of activator calcium available for channel activation is unknown. It is feasible that the availability of calcium required for channel activation is reduced in the IR state, leading to decreased channel Po and a depression of macroscopic BKCa current density. In support of this hypothesis, previous studies (3) have reported that insulin inhibits agonist-induced Ca2+ transients, possibly by closing voltage- and receptor-operated Ca2+ channels, inhibiting inositol (1,4,5)-trisphospate-induced Ca2+ release, or stimulating sarcolemmal Ca2+-ATPase to enhance transmembrane Ca2+ efflux. Furthermore, it has been shown that calcium transients or sparks may be a source of activator calcium to stimulate BKCa channel opening (30). It is possible that IR-induced depression of calcium release mechanisms and/or calcium spark activity could explain the present findings, and such depression of calcium release has been demonstrated in myocardial cells from streptozotocin-diabetic rats (31); however, potential effects of IR on ryanodine receptor function are unknown. Thus further experiments are required to clearly define the molecular mechanism responsible for the decreased BKCa current density we observed. Nonetheless, the present results suggest that the depression of potassium current in VSMC from IR animals is not related to a decrease in channel expression or a change in the biophysical properties (i.e., conductance and voltage and calcium sensitivity) of single BKCa channels.
In summary, our data clearly indicate that BKCa channel activity is reduced in mesenteric small arteries from fructose-fed IR rats. Although this is a dietary-dependent model of IR, animals exhibit all the typical clinical characteristics of IR, including hyperinsulinemia, glucose intolerance, increased triglycerides, and low high-density lipoprotein-cholesterol, as we have previously reported (26). We propose that this mechanism may contribute to impaired vascular relaxation and the development of hypertension in the IR state. Further experiments are necessary to investigate the time progression of changes in channel function in the IR state and to define the molecular nature of these alterations.
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Dr. Hans Gunther for providing the antibody.
| |
FOOTNOTES |
|---|
This work was supported in part by National Heart, Lung, and Blood Institute Grants HL-64779 (to R. E. White and G. O. Carrier), HL-54844 (to R. E. White) and HL-49924 (to L. C. Fuchs) and by the American Heart Association (to A. W. Miller, G. O. Carrier, R. E. White, and L. C. Fuchs).
Address for reprint requests and other correspondence: C. Dimitropoulou, Dept. of Pharmacology and Toxicology, Medical College of Georgia, 1120 15th St., Augusta, GA 30912-2300 (E-mail: cdimitro{at}mail.mcg.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
10.1152/ajpheart.00382.2001
Received 8 May 2001; accepted in final form 15 October 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Bakker, EN,
and
Sipkema P.
Components of acetylcholine-induced dilation in isolated rat arterioles.
Am J Physiol Heart Circ Physiol
273:
H1848-H1853,
1997.
2.
Banskota, NK,
Taub R,
Zellner K,
and
King GL.
Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of the protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells.
Mol Endocrinol
3:
1183-1190,
1989.
3.
Berweck, S,
Thieme H,
Lepple-Wienhues A,
Helbig H,
and
Wiederholt M.
Insulin-induced hyperpolarization in retinal capillary pericytes.
Invest Ophthalmol Vis Sci
34:
3402-3407,
1993.
4.
Bhanot, S,
McNeill JH,
and
Bryer-Ash M.
Vanadyl sulfate prevents fructose-induced hyperinsulinemia and hypertension in rats.
Hypertension
23:
308-312,
1994.
5.
Bolton, TB,
and
Pacaud P.
Voltage-dependent calcium channels of smooth muscle.
Jpn J Pharmacol
58:
251P-257P,
1992.
6.
Calver, A,
Collier J,
Moncada S,
and
Vallance P.
Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal.
J Hypertens
10:
1025-1031,
1992.
7.
Carrier, GO,
Fuchs LC,
Winecoff AP,
Giulumian AD,
and
White RE.
Nitrovasodilators relax mesenteric microvessels by cGMP-induced stimulation of Ca-activated K channels.
Am J Physiol Heart Circ Physiol
273:
H76-H84,
1997.
8.
Cleland, SJ,
Petrie JR,
Ueda S,
Elliott HL,
and
Connell JM.
Insulin as a vascular hormone: implications for the pathophysiology of cardiovascular disease.
Clin Exp Pharmacol Physiol
25:
175-184,
1998.
9.
Cui, J,
Cox DH,
and
Aldrich RW.
Intrinsic voltage dependence and Ca2+ regulation of mslo large conductance Ca-activated K+ channels.
J Gen Physiol
109:
647-673,
1997.
10.
Dimitropoulou, C,
White RE,
Fuchs L,
Zhang H,
Catravas JD,
and
Carrier GO.
Angiotensin II relaxes microvessels via the AT2 receptor and Ca2+-activated K+ (BKCa) channels.
Hypertension
37:
301-307,
2001.
11.
Ferrannini, E,
Buzzigoli G,
Bonadonna R,
Giorico MA,
Oleggini M,
Graziadei L,
Pedrinelli R,
Brandi L,
and
Bevilacqua S.
Insulin resistance in essential hypertension.
N Engl J Med
317:
350-357,
1987.
12.
Fontbonne, A,
Charles MA,
Thibult N,
Richard JL,
Claude JR,
Warnet JM,
Rosselin GE,
and
Eschwege E.
Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up.
Diabetologia
34:
356-361,
1991.
13.
Herbert, V,
Lau KS,
Gottlieb CW,
and
Bleicher SJ.
Coated charcoal immunoassay of insulin.
J Clin Endocrinol Metab
25:
1375-1384,
1965.
14.
Hsueh, WA,
and
Law RE.
Pharmacological treatment and mechanisms of insulin resistance Impact on vascular smooth muscle cells, blood pressure, and lipids.
Ann NY Acad Sci
827:
170-177,
1997.
15.
Hwang, IS,
Ho H,
Hoffman BB,
and
Reaven GM.
Fructose-induced insulin resistance and hypertension in rats.
Hypertension
10:
512-516,
1987.
16.
Kahn, AM,
Husid A,
Odebunmi T,
Allen JC,
Seidel CL,
and
Song T.
Insulin inhibits vascular smooth muscle contraction at a site distal to intracellular Ca2+ concentration.
Am J Physiol Endocrinol Metab
274:
E885-E892,
1998.
17.
Katakam, PV,
Ujhelyi MR,
Hoenig ME,
and
Miller AW.
Endothelial dysfunction precedes hypertension in diet-induced insulin resistance.
Am J Physiol Regulatory Integrative Comp Physiol
275:
R788-R792,
1998.
18.
Katakam, PV,
Ujhelyi MR,
and
Miller AW.
EDHF-mediated relaxation is impaired in fructose-fed rats.
J Cardiovasc Pharmacol
34:
461-467,
1999.
19.
Knaus, HG,
Folander K,
Garcia-Calvo M,
Garcia ML,
Kaczorowski GJ,
Smith M,
and
Swanson R.
Primary sequence and immunological characterization of beta-subunit of high conductance Ca2+-activated K+ channel from smooth muscle.
J Biol Chem
269:
17274-17278,
1994.
20.
Knaus, HG,
Eberhart A,
Koch RO,
Munujos P,
Schmalhofer WA,
Warmke JW,
Kaczorowski GJ,
and
Garcia ML.
Characterization of tissue-expressed alpha subunits of the high conductance Ca2+-activated K+ channel.
J Biol Chem
270:
22434-22439,
1995.
21.
Lind, L,
Berne C,
and
Lithell H.
Prevalence of insulin resistance in essential hypertension.
J Hypertens
13:
1457-1462,
1995.
22.
Liu, Y,
Hudetz AG,
Knaus HG,
and
Rusch NJ.
Increased expression of Ca2+-sensitive K+ channels in the cerebral microcirculation of genetically hypertensive rats: evidence for their protection against cerebral vasospasm.
Circ Res
82:
729-737,
1998.
23.
Liu, Y,
Jones AW,
and
Sturek M.
Ca2+-dependent K+ current in arterial smooth muscle cells from aldosterone-salt hypertensive rats.
Am J Physiol Heart Circ Physiol
269:
H1246-H1257,
1995.
24.
Liu, Y,
Pleyte K,
Knaus HG,
and
Rusch NJ.
Increased expression of Ca2+-sensitive K+ channels in aorta of hypertensive rats.
Hypertension
30:
1403-1409,
1997.
25.
Miller, AW,
Hoenig ME,
and
Ujhelyi MR.
Mechanisms of impaired endothelial function associated with insulin resistance.
J Cardiovasc Pharmacol
3:
125-134,
1998.
26.
Miller, AW,
Katakam PV,
and
Ujhelyi MR.
Impaired endothelium-mediated relaxation in coronary arteries from insulin-resistant rats.
J Vasc Res
36:
385-392,
1999.
27.
Mitchell, BD,
Haffner SM,
Hazuda HP,
Valdez R,
and
Stern MP.
The relation between serum insulin levels and 8-year changes in lipid, lipoprotein, and blood pressure levels.
Am J Epidemiol
136:
12-22,
1992.
28.
Mitrakou, A,
Mokan M,
Bolli G,
Veneman T,
Jenssen T,
Cryer P,
and
Gerich J.
Evidence against the hypothesis that hyperinsulinemia increases sympathetic nervous system activity in man.
Metabolism
41:
198-200,
1992.
29.
Mombouli, JV,
and
Vanhoutte PM.
Endothelium-derived hyperpolarizing factor(s): updating the unknown.
Trends Pharmacol Sci
18:
252-256,
1997.
30.
Nelson, MT,
Cheng H,
Rubart M,
Santana LF,
Bonev AD,
Knot HJ,
and
Lederer WJ.
Relaxation of arterial smooth muscle by calcium sparks.
Science
270:
633-637,
1995.
31.
Netticadan, T,
Temsah RM,
Kent A,
Elimban V,
and
Dhalla NS.
Depressed levels of Ca2+-cycling proteins may underlie sarcoplasmic reticulum dysfunction in the diabetic heart.
Diabetes
50:
2133-2138,
2001.
32.
O'Brien, SF,
Russell JC,
and
Davidge ST.
Vascular wall dysfunction in JCR:LA-cp rats: effects of age and insulin resistance.
Am J Physiol Cell Physiol
277:
C987-C993,
1999.
33.
Pluger, S,
Faulhaber J,
Furstenau M,
Lohn M,
Waldschutz R,
Gollasch M,
Haller H,
Luft FC,
Ehmke H,
and
Pongs O.
Mice with disrupted BK channel ss1 subunit gene feature abnormal Ca2+ Spark/STOC coupling and elevated blood pressure.
Circ Res
87:
E53-E60,
2000.
34.
Rubanyi, GM.
The role of endothelium in cardiovascular homeostasis and diseases.
J Cardiovasc Pharmacol
22:
S1-S14,
1993.
35.
Sax, FL,
Cannon ROD,
Hanson C,
and
Epstein SE.
Impaired forearm vasodilator reserve in patients with microvascular angina: evidence of a generalized disorder of vascular function? [Erratum. N Engl J Med. 317: 1987 Dec 24, p. 1674].
N Engl J Med
317:
1366-1370,
1987.
36.
Shimoni, Y,
Severson D,
and
Ewart HS.
Insulin resistance and the modulation of rat cardiac K+ currents.
Am J Physiol Heart Circ Physiol
279:
H639-H649,
2000.
37.
Shinozaki, K,
Suzuki M,
Ikebuchi M,
Takaki H,
Hara Y,
Tsushima M,
and
Harano Y.
Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for vasospastic angina.
Circulation
92:
1749-1757,
1995.
38.
Soria, B.
The biophysical basis of K channel pharmacology.
In: Ion Channel Pharmacology, edited by Soria B,
and Cena V. New York: Oxford University Press, 1998, p. 167-185.
39.
Star, RA.
Nitric oxide.
Am J Med Sci
306:
348-358,
1993.
40.
Steinberg, HO,
Chaker H,
Leaming R,
Johnson A,
Brechtel G,
and
Baron AD.
Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.
J Clin Invest
97:
2601-2610,
1996.
41.
Supiano, MA,
Hogikyan RV,
Morrow LA,
Ortiz-Alonso FJ,
Herman WH,
Bergman RN,
and
Halter JB.
Hypertension and insulin resistance: role of sympathetic nervous system activity.
Am J Physiol Endocrinol Metab
263:
E935-E942,
1992.
42.
Verma, S,
Bhanot S,
and
McNeill JH.
Sympathectomy prevents fructose-induced hyperinsulinemia and hypertension.
Eur J Pharmacol
373:
R1-R4,
1999.
43.
White, RE,
Darkow DJ,
and
Lang JL.
Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism.
Circ Res
77:
936-942,
1995.
44.
Williams, SB,
Cusco JA,
Roddy MA,
Johnstone MT,
and
Creager MA.
Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus.
J Am Coll Cardiol
27:
567-574,
1996.
This article has been cited by other articles:
![]() |
Shu Zhu, R. E. White, and S. A. Barman Original Research: Role of phosphodiesterases in modulation of BKCa channels in hypertensive pulmonary arterial smooth muscle Therapeutic Advances in Respiratory Disease, June 1, 2008; 2(3): 119 - 127. [Abstract] [PDF] |
||||
![]() |
M. K. McGahon, D. P. Dash, A. Arora, N. Wall, J. Dawicki, D. A. Simpson, C. N. Scholfield, J. G. McGeown, and T. M. Curtis Diabetes Downregulates Large-Conductance Ca2+-Activated Potassium {beta}1 Channel Subunit in Retinal Arteriolar Smooth Muscle Circ. Res., March 16, 2007; 100(5): 703 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lu, T. He, Z. S. Katusic, and H.-C. Lee Molecular Mechanisms Mediating Inhibition of Human Large Conductance Ca2+-Activated K+ Channels by High Glucose Circ. Res., September 15, 2006; 99(6): 607 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Burnham, I. T. Johnson, and A. H. Weston Reduced Ca2+-dependent activation of large-conductance Ca2+-activated K+ channels from arteries of Type 2 diabetic Zucker diabetic fatty rats Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1520 - H1527. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lu, X.-L. Wang, T. He, W. Zhou, T. L. Kaduce, Z. S. Katusic, A. A. Spector, and H.-C. Lee Impaired Arachidonic Acid-Mediated Activation of Large-Conductance Ca2+-Activated K+ Channels in Coronary Arterial Smooth Muscle Cells in Zucker Diabetic Fatty Rats Diabetes, July 1, 2005; 54(7): 2155 - 2163. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Miller, C. D. Tulbert, and D. W. Busija Rosuvastatin treatment reverses impaired coronary artery vasodilation in fructose-fed, insulin-resistant rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R157 - R160. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Barman, S. Zhu, and R. E. White PKC activates BKCa channels in rat pulmonary arterial smooth muscle via cGMP-dependent protein kinase Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1275 - L1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Erdos, J. A. Snipes, A. W. Miller, and D. W. Busija Cerebrovascular Dysfunction in Zucker Obese Rats Is Mediated by Oxidative Stress and Protein Kinase C Diabetes, May 1, 2004; 53(5): 1352 - 1359. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Erdos, S. A. Simandle, J. A. Snipes, A. W. Miller, and D. W. Busija Potassium Channel Dysfunction in Cerebral Arteries of Insulin-Resistant Rats Is Mediated by Reactive Oxygen Species Stroke, April 1, 2004; 35(4): 964 - 969. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Barman, S. Zhu, and R. E. White Protein kinase C inhibits BKCa channel activity in pulmonary arterial smooth muscle Am J Physiol Lung Cell Mol Physiol, January 1, 2004; 286(1): L149 - L155. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Barman, S. Zhu, G. Han, and R. E. White cAMP activates BKCa channels in pulmonary arterial smooth muscle via cGMP-dependent protein kinase Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L1004 - L1011. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||